Chargement en cours...
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
BACKGROUND: There is no consensus on the optimal initial treatment for polypoidal choroidal vasculopathy (PCV). Our study aimed to report the efficacy of repeated injections of intravitreal ranibizumab with or without photodynamic therapy for the treatment of PCV and to determine the possible factor...
Enregistré dans:
| Publié dans: | BMC Ophthalmol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6642544/ https://ncbi.nlm.nih.gov/pubmed/31324161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-019-1156-4 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|